Tag: advogains

CLM – Moving from siloed disease specific intervention

On March 12, 2025, during data collection process, a dialysis patient, who has been undergoing routine dialysis for the past 13 years and is living with a disability due to a previous accident, was identified as hepatitis C positive. On March 13, 2025, the data enumerator met the person at RS Pengayoman, coinciding with the […]

Stigma and discrimination issue resolved

Through the information dissemination of the India HIV/AIDS Act 2017, we have recorded an increased level of awareness of the act among care recipients. A woman living with HIV, during September, came forward and filed a complaint at CoNE’s Legal AIDS Center about discrimination based on her HIV status by her neighbor. The case was […]

CLM serving as avenue for treatment education and retention

A 28-year-old male, living with HIV due to vertical transmission, initiated antiretroviral therapy with Tenofovir/lamivudine/efavirenz at Jawaharlal Nehru Institute of Medical Sciences (JNIMS), on 12th September 2005. However, due to lack of knowledge about HIV and need for continuously adhering to treatment, he discontinued treatment on 4th May 2021, expressing treatment burn-out. Action taken: After […]

Initiating HIV treatment: People still needs support

A person of 24 years young male tested HIV positive on October 28, 2024, at the Integrated counselling and Testing centre at the Regional Institute of Medical Sciences in Imphal. The individual requested help to guide through the treatment initiation process. Action taken: The data enumerators provided guidance to the individual in undergoing clinical baseline […]

Re-linking to HIV treatment after 6 years

A young woman of 18 years, living with HIV through vertical transmission, initiated antiretroviral therapy in 2018. She discontinued her treatment just after one month. Over the past six years, she consistently resisted resuming the therapy. Action taken: Multiple counselling sessions by the staff of CoNE, she finally agreed to re-start HIV treatment. On November […]